机器学习模型在减少不必要的前列腺活检中的比较性能。

IF 8.3 1区 医学 Q1 ONCOLOGY
Fuyao Chen, Roxana Esmaili, Ghazal Khajir, Tal Zeevi, Moritz Gross, Michael Leapman, Preston Sprenkle, Amy C Justice, Sandeep Arora, Jeffrey C Weinreb, Michael Spektor, Steffan Huber, Peter A Humphrey, Angelique Levi, Lawrence H Staib, Rajesh Venkataraman, Darryl T Martin, John A Onofrey
{"title":"机器学习模型在减少不必要的前列腺活检中的比较性能。","authors":"Fuyao Chen, Roxana Esmaili, Ghazal Khajir, Tal Zeevi, Moritz Gross, Michael Leapman, Preston Sprenkle, Amy C Justice, Sandeep Arora, Jeffrey C Weinreb, Michael Spektor, Steffan Huber, Peter A Humphrey, Angelique Levi, Lawrence H Staib, Rajesh Venkataraman, Darryl T Martin, John A Onofrey","doi":"10.1016/j.euo.2025.01.005","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>Conventional core needle biopsy for prostate cancer diagnosis can lead to diagnostic uncertainty and complications, prompting exploration of alternative risk assessment approaches that use clinical and imaging features. Our aim was to evaluate the effectiveness of machine learning (ML) models in reducing unnecessary biopsies.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of data for 1884 patients across two academic centers who underwent prostate magnetic resonance imaging and biopsy between 2016 and 2020 or 2004 and 2011. Twelve ML models were assessed for prediction of clinically significant prostate cancer (csPCa; Gleason grade group ≥2) using combinations of clinical features, including patient age, prostate-specific antigen level and density, Prostate Imaging-Reporting and Data System/Likert score, lesion volume, and gland volume. The models were trained and validated using a tenfold split for intrasite, intersite, and combined-site data sets. Model effectiveness was evaluated using the area under the receiver operating characteristic curve and decision curve analysis.</p><p><strong>Key findings and limitations: </strong>The best-performing ML model would reduce the number of biopsies by 13.07% at a false-negative rate of 1.91%. Performance was consistent across sites, although the study is limited by the small number of centers and the absence of specific clinical data.</p><p><strong>Conclusions and clinical implications: </strong>ML-enhanced clinical models provide an effective and generalizable approach for prediction of csPCa using standard clinical data. These models allow personalized risk assessment and follow-up, support clinical decision-making, and improve workflow efficiency.</p><p><strong>Patient summary: </strong>Models that are enhanced by machine learning can predict the severity of prostate cancer and help doctors in tailoring treatments for individual patients. This approach can simplify health care decisions and improve clinical efficiency.</p>","PeriodicalId":12256,"journal":{"name":"European urology oncology","volume":" ","pages":""},"PeriodicalIF":8.3000,"publicationDate":"2025-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparative Performance of Machine Learning Models in Reducing Unnecessary Targeted Prostate Biopsies.\",\"authors\":\"Fuyao Chen, Roxana Esmaili, Ghazal Khajir, Tal Zeevi, Moritz Gross, Michael Leapman, Preston Sprenkle, Amy C Justice, Sandeep Arora, Jeffrey C Weinreb, Michael Spektor, Steffan Huber, Peter A Humphrey, Angelique Levi, Lawrence H Staib, Rajesh Venkataraman, Darryl T Martin, John A Onofrey\",\"doi\":\"10.1016/j.euo.2025.01.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objective: </strong>Conventional core needle biopsy for prostate cancer diagnosis can lead to diagnostic uncertainty and complications, prompting exploration of alternative risk assessment approaches that use clinical and imaging features. Our aim was to evaluate the effectiveness of machine learning (ML) models in reducing unnecessary biopsies.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of data for 1884 patients across two academic centers who underwent prostate magnetic resonance imaging and biopsy between 2016 and 2020 or 2004 and 2011. Twelve ML models were assessed for prediction of clinically significant prostate cancer (csPCa; Gleason grade group ≥2) using combinations of clinical features, including patient age, prostate-specific antigen level and density, Prostate Imaging-Reporting and Data System/Likert score, lesion volume, and gland volume. The models were trained and validated using a tenfold split for intrasite, intersite, and combined-site data sets. Model effectiveness was evaluated using the area under the receiver operating characteristic curve and decision curve analysis.</p><p><strong>Key findings and limitations: </strong>The best-performing ML model would reduce the number of biopsies by 13.07% at a false-negative rate of 1.91%. Performance was consistent across sites, although the study is limited by the small number of centers and the absence of specific clinical data.</p><p><strong>Conclusions and clinical implications: </strong>ML-enhanced clinical models provide an effective and generalizable approach for prediction of csPCa using standard clinical data. These models allow personalized risk assessment and follow-up, support clinical decision-making, and improve workflow efficiency.</p><p><strong>Patient summary: </strong>Models that are enhanced by machine learning can predict the severity of prostate cancer and help doctors in tailoring treatments for individual patients. This approach can simplify health care decisions and improve clinical efficiency.</p>\",\"PeriodicalId\":12256,\"journal\":{\"name\":\"European urology oncology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":8.3000,\"publicationDate\":\"2025-02-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European urology oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.euo.2025.01.005\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European urology oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.euo.2025.01.005","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景和目的:前列腺癌诊断的常规穿刺活检可能导致诊断不确定性和并发症,促使人们探索利用临床和影像学特征的替代风险评估方法。我们的目的是评估机器学习(ML)模型在减少不必要的活检方面的有效性。方法:我们对2016年至2020年或2004年至2011年期间接受前列腺磁共振成像和活检的两个学术中心的1884名患者的数据进行了回顾性分析。对12个ML模型进行评估,以预测临床显著性前列腺癌(csPCa;Gleason分级组≥2),结合临床特征,包括患者年龄、前列腺特异性抗原水平和密度、前列腺成像报告和数据系统/Likert评分、病变体积和腺体体积。使用10倍的站点内、站点间和组合站点数据集对模型进行训练和验证。采用受试者工作特征曲线下面积和决策曲线分析评价模型的有效性。主要发现和局限性:表现最好的ML模型将减少13.07%的活检次数,假阴性率为1.91%。尽管研究受到中心数量少和缺乏具体临床数据的限制,但在不同地点的表现是一致的。结论和临床意义:ml增强的临床模型为使用标准临床数据预测csPCa提供了有效和可推广的方法。这些模型允许个性化风险评估和随访,支持临床决策,提高工作流程效率。患者总结:通过机器学习增强的模型可以预测前列腺癌的严重程度,并帮助医生为个别患者量身定制治疗方案。这种方法可以简化医疗保健决策,提高临床效率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Comparative Performance of Machine Learning Models in Reducing Unnecessary Targeted Prostate Biopsies.

Background and objective: Conventional core needle biopsy for prostate cancer diagnosis can lead to diagnostic uncertainty and complications, prompting exploration of alternative risk assessment approaches that use clinical and imaging features. Our aim was to evaluate the effectiveness of machine learning (ML) models in reducing unnecessary biopsies.

Methods: We conducted a retrospective analysis of data for 1884 patients across two academic centers who underwent prostate magnetic resonance imaging and biopsy between 2016 and 2020 or 2004 and 2011. Twelve ML models were assessed for prediction of clinically significant prostate cancer (csPCa; Gleason grade group ≥2) using combinations of clinical features, including patient age, prostate-specific antigen level and density, Prostate Imaging-Reporting and Data System/Likert score, lesion volume, and gland volume. The models were trained and validated using a tenfold split for intrasite, intersite, and combined-site data sets. Model effectiveness was evaluated using the area under the receiver operating characteristic curve and decision curve analysis.

Key findings and limitations: The best-performing ML model would reduce the number of biopsies by 13.07% at a false-negative rate of 1.91%. Performance was consistent across sites, although the study is limited by the small number of centers and the absence of specific clinical data.

Conclusions and clinical implications: ML-enhanced clinical models provide an effective and generalizable approach for prediction of csPCa using standard clinical data. These models allow personalized risk assessment and follow-up, support clinical decision-making, and improve workflow efficiency.

Patient summary: Models that are enhanced by machine learning can predict the severity of prostate cancer and help doctors in tailoring treatments for individual patients. This approach can simplify health care decisions and improve clinical efficiency.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
15.50
自引率
2.40%
发文量
128
审稿时长
20 days
期刊介绍: Journal Name: European Urology Oncology Affiliation: Official Journal of the European Association of Urology Focus: First official publication of the EAU fully devoted to the study of genitourinary malignancies Aims to deliver high-quality research Content: Includes original articles, opinion piece editorials, and invited reviews Covers clinical, basic, and translational research Publication Frequency: Six times a year in electronic format
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信